- Previous Close
142.00 - Open
146.00 - Bid 145.00 x --
- Ask 146.00 x --
- Day's Range
146.00 - 146.00 - 52 Week Range
124.00 - 170.30 - Volume
2,584 - Avg. Volume
12,303 - Market Cap (intraday)
3.971B - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
26.59 - EPS (TTM)
5.49 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 9.19 (6.30%)
- Ex-Dividend Date Apr 17, 2025
- 1y Target Est
--
Brighten Optix Corporation researches, develops, manufactures, and sells contact lenses in Taiwan and internationally. The company offers orthokeratology, a non-invasive and reversible method of vision correction by using a hard contact lens to alter the shape of the front surface of the cornea; gas permeable lenses for single vison, multifocal, and irregular cornea and keratoconus correction, under the HiClear, So2clear, Menicon, Duette, ROSE K, Ampleye, MAXIM 3D, AND ULTRAHEALTH brand name; and soft contact lenses under the iDealsoft, Briomoist, and Altius brand name. It also provides spectacle lenses to correct myopia in children under the Bestivue; and lens care solutions for hard and soft contact lens, and rewetting drops. Brighten Optix Corporation was founded in 1965 and is based in Taipei, Taiwan.
www.brightenoptix.com.twRecent News: 6747.TWO
View MorePerformance Overview: 6747.TWO
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6747.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6747.TWO
View MoreValuation Measures
Market Cap
3.97B
Enterprise Value
3.33B
Trailing P/E
26.59
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.20
Price/Book (mrq)
2.81
Enterprise Value/Revenue
4.34
Enterprise Value/EBITDA
14.03
Financial Highlights
Profitability and Income Statement
Profit Margin
19.53%
Return on Assets (ttm)
6.38%
Return on Equity (ttm)
10.95%
Revenue (ttm)
766.93M
Net Income Avi to Common (ttm)
149.79M
Diluted EPS (ttm)
5.49
Balance Sheet and Cash Flow
Total Cash (mrq)
669.73M
Total Debt/Equity (mrq)
2.06%
Levered Free Cash Flow (ttm)
76.62M